{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:18:07Z","timestamp":1788164287362,"version":"build-2803163510"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"73","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is substantial evidence examining effectiveness of human papillomavirus vaccines in populations using registry linkages. These studies initially mapped early outcomes, but in recent years have focused on harder endpoints, confirming that the vaccines have the anticipated effect against infection, lesions, and ultimately invasive cervical cancer. It is generally accepted that when vaccinated cohorts enter screening programs, adjustments to screening strategies are needed to maintain the balance of benefits and harms and achieve optimal resource use. The purpose of this chapter is to examine the practical considerations for implementing tailored screening in the context of increasingly vaccinated populations, with particular emphasis on data sources and their application in routine practice. We present real-world examples of linking vaccination and screening registries to enable screening strategies informed by individual human papillomavirus vaccination status. We also outline the common challenges encountered when establishing such linkages and offer practical suggestions for overcoming them.<\/jats:p>","DOI":"10.1093\/jncimonographs\/lgag014","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:38:29Z","timestamp":1779190709000},"page":"180-186","source":"Crossref","is-referenced-by-count":0,"title":["How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers"],"prefix":"10.1093","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-4050","authenticated-orcid":false,"given":"Partha","family":"Basu","sequence":"first","affiliation":[{"name":"Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lucas","sequence":"additional","affiliation":[{"name":"Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0514-7226","authenticated-orcid":false,"given":"K Miriam","family":"Elfstr\u00f6m","sequence":"additional","affiliation":[{"name":"Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026083104015480500_lgag014-B1","volume-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","author":"World Health Organization","year":"2020"},{"key":"2026083104015480500_lgag014-B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet (London, England)"},{"key":"2026083104015480500_lgag014-B3","doi-asserted-by":"publisher","first-page":"e39915","DOI":"10.1371\/journal.pone.0039915","article-title":"A protocol for the secure linking of registries for HPV surveillance","volume":"7","author":"El Emam","year":"2012","journal-title":"PLoS One"},{"key":"2026083104015480500_lgag014-B4","volume-title":"Cancer Screening in Five Continents.","author":"Lucas","year":"2025"},{"key":"2026083104015480500_lgag014-B5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"2026083104015480500_lgag014-B6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/s1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","volume":"17","author":"Kavanagh","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026083104015480500_lgag014-B7","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1158\/1055-9965.epi-14-0687","article-title":"Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study","volume":"23","author":"S\u00f6derlund-Strand","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2026083104015480500_lgag014-B8","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"2026083104015480500_lgag014-B9","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/s0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet (London, England)"},{"key":"2026083104015480500_lgag014-B10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026083104015480500_lgag014-B11","doi-asserted-by":"publisher","first-page":"101178","DOI":"10.1016\/j.lanepe.2024.101178","article-title":"Effectiveness of quadrivalent human papillomavirus vaccination against high-grade cervical lesions by age and doses: a population-based cohort study","volume":"49","author":"Wu","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"2026083104015480500_lgag014-B12","doi-asserted-by":"publisher","first-page":"100685","DOI":"10.1016\/j.jvacx.2025.100685","article-title":"HPV vaccination campaigns in Ethiopia and Bangladesh: strategic implementation, challenges, identifying best practices and lessons for success in low and middle-income countries","volume":"25","author":"Sayem","year":"2025","journal-title":"Vaccine: X"},{"key":"2026083104015480500_lgag014-B13","author":"Isabelle Tschan","year":"2026"},{"key":"2026083104015480500_lgag014-B14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.puhe.2024.12.010","article-title":"Prioritizing performance and outcome indicators for quality assessment of cancer screening programs in the EU","volume":"239","author":"Sheridan","year":"2025","journal-title":"Public Health"},{"key":"2026083104015480500_lgag014-B15","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1093\/infdis\/jiaf032","article-title":"Population-based age-period-cohort analysis of declining human papillomavirus prevalence","volume":"231","author":"Gray","year":"2025","journal-title":"J Infect Dis"},{"key":"2026083104015480500_lgag014-B16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41591-023-02315-6","article-title":"CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs","volume":"29","author":"Zhang","year":"2023","journal-title":"Nat Med"},{"key":"2026083104015480500_lgag014-B17","author":"National Board of Health and Welfare","year":"2022"},{"key":"2026083104015480500_lgag014-B18","doi-asserted-by":"publisher","first-page":"9691413251362597","DOI":"10.1177\/09691413251362597","article-title":"Quality indicators for cervical screening in Sweden","author":"Andersson","year":"2025","journal-title":"J Med Screen"},{"key":"2026083104015480500_lgag014-B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ypmed.2016.11.020","article-title":"Cervical cancer screening in women vaccinated against human papillomavirus infection: recommendations from a consensus conference","volume":"98","author":"Giorgi Rossi","year":"2017","journal-title":"Prev Med"},{"key":"2026083104015480500_lgag014-B20","author":"World Health Organization","year":"2015"},{"key":"2026083104015480500_lgag014-B21","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1016\/s2214-109x(19)30048-8","article-title":"Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study","volume":"7","author":"Arrossi","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026083104015480500_lgag014-B22","doi-asserted-by":"publisher","first-page":"100208","DOI":"10.1016\/j.pvr.2020.100208","article-title":"Strong reduction in prevalence of HPV16\/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina","volume":"10","author":"Gonz\u00e1lez","year":"2020","journal-title":"Papillomavirus Research (Amsterdam, Netherlands)"},{"key":"2026083104015480500_lgag014-B23","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1186\/s12889-025-22668-6","article-title":"Implementation of an electronic health information system using DHIS2 tracker to manage and evaluate the National cervical screening programme in Bangladesh","volume":"25","author":"Nessa","year":"2025","journal-title":"BMC Public Health"},{"key":"2026083104015480500_lgag014-B24","author":"Country Learning Hub in Bangladesh"},{"key":"2026083104015480500_lgag014-B25","author":"European Commission, Joint Research Centre and International Agency for Research on Cancer"},{"key":"2026083104015480500_lgag014-B26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ygyno.2025.03.008","article-title":"Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: a systematic review of population level data and modelling studies","volume":"195","author":"de Bondt","year":"2025","journal-title":"Gynecol Oncol"}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2026\/73\/180\/70870257\/lgag014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2026\/73\/180\/70870257\/lgag014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:01:58Z","timestamp":1788163318000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncimono\/article\/2026\/73\/180\/8776088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":26,"journal-issue":{"issue":"73","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgag014","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"value":"1052-6773","type":"print"},{"value":"1745-6614","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8,1]]}}}